Halting the progression of renal disease: where we stand?
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000628:therapy; D018450:Disease Progression; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology; D007564:Japan / Q000453:epidemiology; D007674:Kidney Diseases / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D011507:Proteinuria / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000806:Angiotensin-Converting Enzyme Inhibitors